Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Systematic review of machine learning for diagnosis and prognosis in dermatology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Caring for young people with moderate to severe psoriasis: an interpretive description of parental perspectives

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Drug survival of secukinumab for psoriasis in a real-world setting

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi Process

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Atopic dermatitis is associated with increased use of social benefits: a register-based cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

OriginalsprogEngelsk
TidsskriftThe Journal of dermatological treatment
Vol/bind30
Udgave nummer4
Sider (fra-til)387-388
Antal sider2
ISSN0954-6634
DOI
StatusUdgivet - jun. 2019

ID: 59165943